Workflow
Critical One Energy Announces Closing of Upsized CDN$1,430,000 Flow-Through Private Placement
TMX Newsfile· 2025-12-19 19:24
Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - Critical One Energy Inc. (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF) ("Critical One" or the "Company") ("Critical One" or the "Company") is pleased to announce that it has closed a non-brokered private placement offering of 1,430,000 flow-through common shares ("FT Shares") at a price of CDN$1.00 per FT Share, for gross proceeds of CDN$1,430,000 (the "Offering").The close of the flow-through private placement upsizes the Company's previously announced offe ...
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
Prnewswire· 2025-12-19 19:23
Underscores Long-Standing Commitment to Investing in Innovation and U.S. Manufacturing ®®® THOUSAND OAKS, Calif., Dec. 19, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced it is taking action again with the U.S. government to lower medicine costs for American patients, while reinforcing Amgen's long-standing commitment to innovation. The action satisfies the components outlined in President Trump's July 31 letter, including the Administration's Most Favored Nation pricing requests. Additional detail ...
TikTok signs joint venture to create TikTok USDS Joint Venture
Youtube· 2025-12-19 19:22
Meanwhile, Oracle is popping today. Another big mover after Tik Tok made major progress to keep US operations going, signing a deal to spin off that unit. And as this new entity now prepares to face off with existing social media giants in the US, how will it fair? Oracle shares, by the way, are up nearly 8%. Julia Borston has more. And Julia, I think Instagram has come a long way this year. The algorithm is much, much better. The competition is a little starker than it used to be. >> Yeah, reals. Also, You ...
Staying away from Nike as it remains in price discovery mode, says KKM Financial's Jeff Kilburg
Youtube· 2025-12-19 19:22
Well, joining us a CNBC contributor and KKM financial founder Jeff Kilberg. Jeff, it's great to have you here, but before I even get in, we're going to start with Nike, but what does it tell you that we're seeing kind of these huge moves across the landscape. Um, I don't know.It feels almost like a more uncertain environment and yet consumer discretionary is outperforming. Maybe the economy is hanging in pretty well, unless you're Nike, as you can see on the screen there. But what do you make of it all.>> W ...
EDF: Changes in the Group's Executive Committee
Globenewswire· 2025-12-19 19:22
Changes in the Group's Executive Committee Following the information and consultation procedures with employee representative bodies, and effective 1 January 2026, EDF's new nuclear activities will be organised around four divisions: • The division of new nuclear project management, responsible for the strategic management of new nuclear programmes, under the responsibility of Xavier Gruz, Group Executive Director. • The division of industrial projects and partnerships, in charge of new nuclear projects m ...
Axon vs. Woodward: Which Aerospace & Defense Stock Should You Bet On?
ZACKS· 2025-12-19 19:21
Key Takeaways AXON is seeing solid demand for TASER, cameras and software, but rising costs and higher debt pressure marginsWWD is gaining from growth in aerospace and industrial units, led by defense demand and power generation needsWoodward's shares have outperformed, aided by improving earnings estimates and a lower valuation versus peers.Axon Enterprise, Inc. (AXON) and Woodward, Inc. (WWD) are two prominent names operating in the aerospace and defense equipment industry. As rivals, these companies are ...
Cintas' Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
ZACKS· 2025-12-19 19:21
Key Takeaways CTAS posted Q2 EPS of $1.21, topping estimates as revenues rose 9.3% year over year to $2.80 billion.Cintas saw broad-based growth, led by First Aid and Safety Services revenues rising 14.3% year over year.CTAS raised FY26 revenue and EPS guidance following strong cash flow and continued shareholder returns.Cintas Corporation (CTAS) reported second-quarter fiscal 2026 (ended Nov. 30, 2025) earnings of $1.21 per share, which beat the Zacks Consensus Estimate of $1.19. The bottom line rose 11% y ...
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Globenewswire· 2025-12-19 19:21
Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation Agreement delivers on President Trump’s four requests, establishing a framework for lower prices for patients in the US and a tariff-free accord for SanofiShowcases commitment to US manufacturing, innovation, and economic growth Paris, December 19, 2025. Sanofi today announced an agreement with President Donald J. Trump's Administration to help ensure American patients have access to more affordable medici ...
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
Businesswire· 2025-12-19 19:21
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with the U.S. government designed to reduce drug costs for Americans, reinforcing the company's long-standing commitment to U.S.-based innovation, affordability, and global health leadership. "This agreement reflects a foundational commitment to both affordability and future innovation, a commitment that we have long seen as essential to shaping the future of healthcare,†said Daniel O'Day, Chairman and Ch ...
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Globenewswire· 2025-12-19 19:21
Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation Agreement delivers on President Trump’s four requests, establishing a framework for lower prices for patients in the US and a tariff-free accord for SanofiShowcases commitment to US manufacturing, innovation, and economic growth Paris, December 19, 2025. Sanofi today announced an agreement with President Donald J. Trump's Administration to help ensure American patients have access to more affordable medici ...